• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/72

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

72 Cards in this Set

  • Front
  • Back
CENTERAL SLEEP APNEA (CSA)
PRIMARY CENTRAL SLEEP APNEA

CHEYNE-STOKES BREATHING PATTERN
MOST COMMON TYPE OF CSA
PTS WITH CHF

HIGH ALTITUDE PERIODIC BREATHING

CENTRAL SLEEP APNEA DUE TO DRUG OR SUBSTANCE
IN ALL TYPES OF CSA, RESPIRATORY EFFORT DECREASES OR STOPS RESULTING IN DROP OR ABSENT OF A/F
RESPIRATORY EVENTS LEAD TO SLEEP FRAGMENTATION AND HYPOXEMIA
MSLT FOLLOW A SLEEP STUDY WITH @ LEAST 6 HOURS OF SLEEP
1.) FIVE MAPS AT TWO HOUR INTERVALS STARTING @ 1.-3 HRS AFTER AWAKENING
2.) SHORTER FOUR HR NAP (NOT RELIABLE FOR DIAGNOSIS OF NARCOLEPSYUNLESS TWO REM ONSETS HAVE OCCURED)
3.) NAPS LAST 15-35 MIN.
4.) LEOG,REOG,CHIN EMG,EEG,( C3-M2,C4-M1,O2-M1,O1-M2) AND ECF ARE RECORDED
STANDARD MSLT INSTRUCTIONS
LIE QUITELY, COMFORTABLE POSITION, KEEP EYES CLOSED AND TRY TO FALL ASLEEP
(THIS IS FOR EACH NAP)
LIGHTS TURNED OFF AND TEST STARTS IMMEDITATELY
TERMINATION OF NAPS ON MSLT
1.)NO SLEEP TERMINATE AFTER 20 MINS. TIMING STARTS FROM LIGHTS OUT.
2.) SLEEP OCCURE TES IS CONTINUED FOR 15 MINS. FROM 1ST EPOCH OF SLEEP
3.)AFTER NAP PT OUT OF BED AND PREVENT FROM SLEEPING PRIOR TO THE NEXT NA[ OPPORTUNITY
TERMINATION OF NAPS ON MSLT
1.)NO SLEEP TERMINATE AFTER 20 MINS. TIMING STARTS FROM LIGHTS OUT.
2.) SLEEP OCCURE TES IS CONTINUED FOR 15 MINS. FROM 1ST EPOCH OF SLEEP
3.)AFTER NAP PT OUT OF BED AND PREVENT FROM SLEEPING PRIOR TO THE NEXT NA[ OPPORTUNITY
DIAGNOSIS OF NARCOLEPSY
1.) 4 NAPS FOR THE DIAGNOSIS IF TWO ARE SOREMPS IN THE FIRST FOUR

2.) FIVE NAPS ARE REQUIRED IF ONLY ONE SOREMP IN THE FIRST FOUR.
EVALUATION OF DAYTIME SLEEPINES
1.) 4 NAPS IN NORMAL SUBJECTS SHOW HIGH TEST-RETEST RELIABILITY
2.) 4 OR 5 NAPS MAY BE DONE
3.)COMPARING MSLT DATAT IN SAME PT THE # OF MAPS (4-5 NAPS) MUST BE RECORDED FOR BOTH SETS OF DATA
4.) # OF NAPS AFFECTS SLEEP LATENCY AND RELIABILITY
RUNNING MSLT
1.) DLEEP ONSET THE 1ST EPOCH SCORED ANY STAGE OF SLEEP (MORE THEN 15) OF A 30 SEC EPOCH
2.) NAP CONTINUES FOR 15 MINS. IF PT SLEEP OR NOT.
3.)NO SLEEP NAP ENDS AFTER 20 MINS.
SCORE MSLT
1.) SLEEP LATENCY (TIME FROM START OF NAP TO SLEEP ONSET) FOR EACH NAP
2.) NO SLEEP OCCURS SLEEP LATENCE IS 20 MINS.
3.) CALCULATE MEAN SLEEP LATENCY (MSL) OF THE 4 OR 5 NAPS
4.) DETERMIN WHICH OF THE NAPS CONTAINS AT LEAST ONE EPOCH OF REM SLEEP
DECTING SOREMPS
1.) ANY EPOCH OF REM WITHIN 15 MINS OF SLEEP ONSET CONSIDERED A SLEEP ONSET REM PERIOD ( SOREMP)
2.) REM EPOCH CONISITS OF > 15 SECS. OF REM SLEEP IN A 60 SEC EPOCH
3.) # OF NAPS CONTAINING REM
4.) REM LATENCY IS TIME FROM SLEEP ONSET TO THE FIRST EPOCH OF REM SLEEP
MWT
1.)4-40MIN TRIALS AT 2 HRS INTERVALS TO BEGIN 1.5-3 HRS AFTER AWAKING
2.) LEOG,REOC, CHIN EMG,EEG (C3A2,C4 A1, O2A1,O1A2 AND ECG ARE RECORDED
3.) PRECEDING PSG IS OPTIONAL
MWT TEST CONDITIONS
1.) RM QUIETWITH NIGHT LIGHT ABOUT 3 FT OFF FLOOR. (7.5 WATT)
2.) PT SEATED IN BED WITH BACK AND HEAD SUPPORTED
3.) TEMP AT PT CONFORT
4.) MEDICATIONS, TOBACCO AND CAFFEIN DETERMINED BY CLINICIAN
5.) OPT DRUG SCREEN
6.) LIGHT BREAFAST ONE HR BEFORE 1ST NAP
7.) LIGHT LUNCH IMMEDIATELY AFTER 2SEC NAP
PT CALIBRATION INSTRUCTIONS FOR MWT
1.) SIT QUITELY WITH EYES OPEN FOR 30 SEC.
2.) WITH OUT MOVING HEAD LOOK (R )THE( L),(R) THEN (L)
3.) BLINK EYES SLOWLY 5 TIMES
4.) CLENCH OR GRIT TEETH TOGETHER
MWT INSTRUCTIONS
1.) SIT STILL AND REMAIN AWAKE AS LONG AS POSSIBLE, LOOK AHEAD AND DO NOT LOOK DIRECTLY AT THE LIGHT
2.) PT NOT ALLOWED TO USE EXTRAORDINARY MEASURES TO STAY AWAKE SUCH AT SLAPPING FACE OR SINGING
3.) SAME INSTRUCTIONS SHOULD BE GIVEN PRIOR TO EVERY TEST
DETERMINATION OF SLEEP ONSET FOR MWT
1.) 1ST EPOCH OF ANY STAGE INCLUDING (N1)
2.) 1ST EPOCH OF DLEEP DEFINED AS MORE THAN 15 SEC. OF ACCCUMULATED SLEEP IN 30 SEC EPOCH
TERMINATION OF MWT TRIALS
1.) NO SLEEP OCCURS EACH TRIAL IS TERMINATED AFTER 40 MIN. TIMING STARTS FROM OVERHEAD LIGHTS OUT.
2.) SLEEP OCCURS THE TEST IS CONTINUED FOR 3 EPOCHS OF STAGE N1 OR THE FIRST EPOCH OF ANY STAGE
3.) AFTER TERMINATION OF TRIAL PT SHOULD GET OUT OF DED AND PREVENTED FROM SLEEPING PRIOR TOE THE NEXT TRIAL
PATH OF SIGNALS FROM PT TO TRACING
BRAIN-ELECTRODE-HEADBOX-AMPLIFIER-COMPUTER-DISPLAY
(SKIN TO SCREEN)
ELECTRODES
1.) RECORDED SIGNAL DETERMINED BY ELECTRODE LOCATION AND LOCATION
EXPLORING ELECTRODE
USED TO OBTAIN A SIGNAL FROM A SPECIFIC AREA
REFERENCE ELECTRODE
PLACED IN AN INACTIVE AREA AND USED TO COMPARE WITH THE EXPLORING ELECTRODE
PAIRING ELECTRODES
ALLOWS YOU TO IDENTIFY THE SOURCE OF ELECTRIACAL ACTIVITY
REFERNTIAL DERIVATION
COMBINING EXPLORING ELECTRODE WITH REFERENCE ELECTRODE
BIPOLAR DERIVATION
COMBINING TWO ELECTRODES TO EACH OTHER
EXAMPLE : ECG & EMG
HEADBOX
INTERMEDIATE CONNECTION CONDUCTING ELECTRIACAL SIGNAL FRON ELECTRODE TO AMPLIFIER BY
1.) INPROVES CONDUCTION BY REDUCING LENGTH OF HIGH RESISTANCE ELECTRODE WIRE
2.) INCREASE PT MOBILITY BY PORTABLE LINK AOR ALL SENSORS THAT EASILY DISCONNECTED FROM RECORDING SYSTEM

CONNECTS TO THE AMPLIFIER VIA SINGLE LOW RESISTANCE WIRE
( SOME ARE COMBINED IN SAME UNIT)
AMPLIFIER
1.)STRENGTH OF THE SIGNAL IS INCREASED WHICH IS DONE BY AMPLIFIER
2.)AMPLIFIER ARE DIFFERENTIAL AMPLIFIERS BECAUSE THEY AMPLIFY THE DIFFERENCE BETWEEN TWO POINTS
3.) THEY CANCEL OUT ANY SIGNALS COMMON TO BOTH INPUTS AND AMPLIFIES ALL OTHERS SIGNALS
4.)THIS GIVES AMPLIFIER ABILITY TO REJECT UNWANTED ELECTRIACAL INTERFERENCE SUCH AS 60HZ INTERFERENCE
AMPLIFIER / COMMON MODE REJECTION
1.)PROCESS OF ELIMINATIONG SINGAL COMMON TO BOTH ELECTRODED
2.
COMMON MODE SIGNAL
(AMPLIFIER)
SIGNAL SHARED BY BOTH INPUTS
DIFFERENTIAL SIGNAL
(AMPLIFIER)
SIGNAL NOT SHARED BY BOTH INPUTS
COMMON MODE REJECTION RATIO (CMRR)
(AMPLIFIER)
EFFECTIVENESS OF THE DIFFERENTIAL AMPLIFIER
CMRR
COMMON MODE SIGNAL : DIFFERENTIAL SIGNAL
REJECTIONG INTERFERENCE
(AMPLIFIER)
HIGHER THE RATIO BETTER THE AMPLIFIER
AMPLIFIERS PROCESS ELECTRIACAL CURRENT IN TWO WAYS
A/C = ALTERNATING CURRENT

DC = DIRECT CURRENT
AMPLIFIER TYPE USED DEPENDS ON CHARACTERISTICS OF RECORDED SIGNAL
AMPLIFIER BOXES TYPICALLY HAVE MULTIPLE AMPLIFIERS BUILT IN THEM

EACH CHANNEL HAS A SINGLE TYPE OF AMPLIFIER
AC AMPLIFIER
FREQUENTLY FROM + TO -
EXAMPLE EEG, EMG, EOG,

VOLTAGE ID UP AND DOWN

TIME IS ACROSS THE PAPER
DC AMPLIFIER
SIGNALS THAT ALWAY FLOW SAME DIRECTION BUT CAN INCREASE OR DECREASE
AC/DC AMPLIFIERS
1.) ALTERNATION CURRENT FLOW CHANGES DIRECTION CONTINUOUSLY
EX: EEG,EMG,EOG

2.) DIRECT CURRENT CURRENT FLOWS IN ONE DIRECTION
EX: CPCP, OXUNETER, PRESSURE TRANSDUCER SIGNALS
DISPLAY FEATURES
GAIN, SENSITIVITY, FILTERS, SAMPLING RATE, MONTAGE, MONITOR SETTINGS
GAIN
INCREASING GAIN=LARGER DEFLECTIONS
SENSITIVITY
SENSITIVITY =VOLTAGE/DEFLECTION
LOW SENSITIVITY SETTING =LARGER DEFLECTION
EXP:
SEN INPUT =
5 50UV = DEF 10MM
10 50UV = DEF 5MM
25 50UV = DEF 2MM

HIGHER SENSITIVITY =SMALLER WAVE(DEF)

SENSITIVITY AFFECTS HOW WAVE IS DISPLAYED
NOT CHANGE ACTUAL VOLTAGE
SENSITIVITY ( PART 2)
SENSITIVITY =VOLTAGE/DEFLECTION

DEFLECTION=VOLTAGE/SENSITIVITY

SENSITIVITY IS INVERSELY PROPORTIONAL TO DEFLECTION AND GIVES A LARGER DEFLECTION
CALCATIONS ON SENSITIVITY
S=7 D=10 V=? V=7X10=70
D=5 V=50 S=? S=50/5=10
V=100 S=5 D=? D=100/5=20
FILTERS
FOCUS ON SIGNAL FREQUENCIES WE WANT TO SEE

ATTENUATE UNWANTED SIGNALS

EACH CHANNEL CAN BE OPTIMIZED BY USING FILTERS AND ALLOW ONLY SIGNALS IN THE DESIRED FREQUENCY RANGE
LOW FREQUENCY FILTER
(LFF)
ASLO KNOWN AS (HIGH PASS FILTERS)

LFF ALLOWS HIGHER FREQUENCIES TO PASS UNCHANGED WHILE LOWER FREQUENCIES ARE ATTENUATED

HIGHER FILTER VALUE MORE LOWER FREQUENCY WAVES ATTENUATED

REMOVES RESPIRATORY AND SWEAT SWAY ARTIFACT

CAUTION FILTER ALSO ATTENUATE DESIRED FREQUESNCIES SUCH AS SLOW WAVE SLEEP
LFF
EMG =0.3HZ
EOG =0.3HZ
EMG =10HZ (CHIN,LEG,
INTERCOSTAL)
ECG =0.3 HZ
HIGH FREQUENCY FILTERS (HFF)
ALSO KNOW AS (LOW PASS) FILTERS

LETS SLOWER WABES THROUGH AND ATTENUATES HIGH FREQUENCIES

USED TO SET HIGH FREQUENCY RECORDING LIMITS

ALLOW RECORDING OF ONLY SLOWER SIGNALS

EX: ELIMINATES MUSCLE ARTIFACT OR EXTERNAL ELECTRICAL ARTIFACT IN EEG CHANNELS

CAN ATTENUATE DESIRED HIGH FREQUENCIES SUCH AS AROUSALS
HIGHT FREQUENCY FILTERS ( HFF)
DETTINGS BY DERIVATION

EEG=35HZ
EOG=35HZ
EMG=100HZ
ECG=70HZ
TIME CONSTANTS
1.) FALL TIME IN SEC. FOR SQ WAVE TO DECAY TO 37%OF MAX AMPLITUDE

LFF DETERMINES FALL TIME CONSTANT

INCREASE LFF DECREASE TIME CONSTANT

2.) RISE CONSTANT SEC. FOR SQ WAVE TO REACH 63% OF MAX AMPLITUDE

HFF DETERMINES RISE TIME CONSTANT
60HZ / NOTCH FILTER
HIGH FREQUENCY ARTIFACT CAUSED BY
1.) HIGH SIGNAL IMPEDANCE
2.) INTERFERENCE FROM ELECTRICAL EQUIPMENT
3.) POOR APPLICATION OF ELECTRODES

CAUTION: IT CAN ATTENUATE EPILEPTIFORM SPIKES AND MUSCLE ACTIVITY
SAMPLE RATE
ELECTRICAL SIGNALS PRODUCE CONTINUOUS OUTPUT. DIGITAL PSG CONVERT CONTINUOUS WAVE FORM INTO NUMERIC VALUES

MEASURE OF HOW FREQUENTLY SIGNAL IS CONVERTED AND IS EXPRESSED IN CYCLES PER SECOND (HZ)

SHAPE OF WAVE IS DETERMINED BY FREQUENTLY THE SIGNAL IS SAMPLED

HIGHER SAMPLING RATE MORE FREQUENTLY SIGNAL SAMPLED


MORE FREQUENT SAMPLING MORE ACCURATE THE SHAPE

MINIMUM ACCEPTABLE SAMPLING RATE IS 2.5 TIMES > THAN HIGHEST HFF
DERIVATION
DIFFERENTIAL AMPLIFIER MEASURES DIFFERENCES IN VOLTAGE BETWEEN TWO INCOMING SIGNALS

G1= EXPLORING
G2= REFERENCE
OR ANOTHER EXPLORING ELECTRODE
MONTAGE
GROUP OF DEVIVATION USED FOR AND PT .
1.) CONSTRUCTED BY ADDING MULTIPLE DERIVATIONS
2.) ON ANALOG SYSTEMS MONTAGE HAS TO BE CONSTRUCTED FOR EACH PT
3.) DIGITAL SYSTEM MONTAGE CAN BE SET IN ADVANCE AND SAVED
SIGNAL POLARITY
(-) OUTPUT VOLTAGE RECORDED WITH (G1) = UPWARD DEFLECTION

(+) OUTPUT VOLTAGE RECORDED (G1)=DOWNWARD DEFLECTION

UPWARD DEFLECTION=(-)
DOWNWARD DEF=(+)
AMPLITUDE
AMOUNT OF FLUCTUATION OF THE SIGNAL (IN MICROVOLTS/MILLIMETER
-UV/MM MEASURED FROM PEAK TO TROUGH


EX: PEAK -50
TROUGH -40
= 40UV
-85--20=65 WITH WAVE GOING UP SO IT IS (+) POLARITY
EOG & EYE MOVEMENTS
EYES TO (R)
EYES LOOKING UP= MEAT IN MIDDLE DEFLECTION

EYES STRAIGHT =STRAIGHT DEFLECTION

EYES (L)
EYES DOWN = OUTWARD DEFLECTION
ELECTROMYOGRAM
3 ELECTRODES USED TO RECORD CHIN

1.) MIDLINE 1 CM ABOVE INFERIOR EDGE OF MANDIBLE
2.) 2CM BELOW INFERIOR EDGE OF MANDIBLE AND 2CM TO THE (R) OF MIDLINE
) PME CM BELOW INFERIOR EDGE OF MANDIBLE & CM TO LEFT OF MIDLINE
LEG (EMG)
BELLY OF ANTERIOR TIBIALIS SPACED 2-4CM APART AWAY FROM BONE AND IN A STRAIGHT LINE

PREP SITES SEPARATE TO AVOID FORMING SALT BRIDGE (FLOW OF ELECTRICAL CURRENT BETWEEN TWO ELCTRODES ) OCCURS WHEN TWO ELECTRODES OCCUPY SAME PREP SITE
SNORING SENSORS
TWO TYPES
1.) ACOUSTIC=MICROPHONE
2. PIEZO= VIBRATIONS DURING SNORING
FLOW SENSORS
MONITOR NASAL AND/OR
ORAL A/F
PNEUMOTACHOMETER
GOLD STANDARD FOR ASSESSMENT A/F
1.) ACCURATE MEASURE OF TV
2.) LIMITED BY REQUIREMENT FOR TIGHT FITTING FACE MASK
NASAL PRESSURE
FLUCTUATION IN NASAL PRESSURE DURING (I) AND (E)

CHANGES IN PRESSURE CHANGE FLOW

PRESSURE CHANGE DETECTED BY NASAL CANNULA CHANGED TO FLOW SIGNAL BY TRANSDUCER

FAIRLY ACCURATE OF A/F
USES A DC AMPLIFIER
NOTE: APNEA & HYPOPNEA CAN NOT BE DIFFERENTIATED BY NASAL PRESSURE

FLAT LINE SIGNAL MAY REPRESENT APNEA OR MOUTH BREATHING
THERMISTOR/THERMOCOUP
DO NOT DIRECTLY MEASURE A/F

DETECT CHANGE IN AIR TEMPERATURE BETWEEN (I) & (E)

QUALITATIVE RATHER THAN QUANTITATIVE SIGNAL
THERMISTORS
MADE FROM MATERIAL WHOSE RESISTANCE TO ELECTRIACL CURRENT VARIES WITH CHANGES IN TEMPERATURE

DEGREE OF CHANGE IN RESISTANCE USED TO REFLECT CHANGE IN A/F HOWEVER CHANGE IN A/F IS NOT DIRECTLY PROPORTIONAL TO CHANGE IN RESISTANCE

SENSOR REQUIRES USE OF POWER SOURCE

CAN NOT TOUCH SKIN OR WILL NOT VARY WITH TEMP. ONLY
THERMOCOUPLES
TWO DIFFERENT METALS BROUGHT TOGETHER PRODUCE MEASURABLE ELECTRICAL CURRENT

CHANGE IN TEMP. CHANGES IN ELECTRICAL CURRRENT BETWEEN METALS

DEGREE OF CHANGE IN VOLTAGE REFLECT CHANGE IN A/F HOWEVER CHANGE IN A/F IS NOT PROPORTIONAL TO CHANGE IN COLTAGE

SENSOR DOES NOT REQUIRE A POWER SOURCE
PARADOXIVAL BREATHING
OUT OF PHASE MOVEMENT OF THORACIC AND ABDOMINAL CAVITIES OCCURS WITH RESPIRATORY MUSCLES DISORDERS OR WITH COMPLETE AND PARTIAL OCCLUSION OF UPPER A/W
EFFORT SENSORS
MEASURE EXPANSION AND CONTRACTION OF THORACIC AND ABDOMINAL CAVITIES REFLECTING EFFORT TO BREATH

INTERCOSTAL EMG= ESOPHAGEAL PRESSURE MANOMETERS

MEASURE EFFORT AND LUNG VOL.

STRAIN GAUGES IMPEDANCE PLETHYSMOGRAPHY INDUCTANCE PLETHYSMOGRAPHY
INDUCTANCE PLETHYSMOGRAPH
MEASURE OF THE OPPOSITION OF A CONDUCTOR TO A CHANGE IN ELECTRICAL CURRENT FLOW
CONDUCTING WIRE IN BELT EFFORT BELTS ON CHEST AND ABDOMEN AND SMALL ELECTRIC CURRENT IS PASSED THROUGH WIRE
CHANGE IN INDUCTANCE IS RELATED TO VOLUME CHANGE AND EFFORT
IF CALIBRATED THE SUM OF TWO SIGNALS ACCURATE MEASURE OF TV

USED WITH CHILDREN PLACED AT NIPPLE SUBAXILLARY
INTERCOSTAL EMG
MEASURE ACTIVITY OF MUSCLES INVOLVED IN BREATHING

ELECTRODES IN SKIN IN THE INTERCOSTAL SPACE AT LOWER RIBS

EFFORT ONLY
ESOPHAGEAL PRESSURE MANOMETRY
REFERENCE STANDARD FOR MEASUREMENT OF RESPIRATORY EFFORT

PASSED THROUGH NOSE AND INTO ESOPHAGUS TO MEASURE PRESSURE CHANGES
INTRAPLEURAL PRESSURE DECTED BY AIR -FILLED BALLOONS OR FLUID-FILLED CATHETERS THAT ARE ATTACHED TO TRANDUCERS AND SIGNAL AMPLIFIERS
RESPIRATORY EFFORT INCREASES AND PRESSURE BECOMES NEGATIVE, RELIABLE ACCURATE QUANTITATIVE MEASURE OF RESPIRATORY EFFORT
NOT USED DUE TO PT COMFORT ISSUES
ESOPHAGEAL PRESSURE MANOMETRY
REFERENCE STANDARD FOR MEASUREMENT OF RESPIRATORY EFFORT

PASSED THROUGH NOSE AND INTO ESOPHAGUS TO MEASURE PRESSURE CHANGES
INTRAPLEURAL PRESSURE DECTED BY AIR -FILLED BALLOONS OR FLUID-FILLED CATHETERS THAT ARE ATTACHED TO TRANDUCERS AND SIGNAL AMPLIFIERS
RESPIRATORY EFFORT INCREASES AND PRESSURE BECOMES NEGATIVE, RELIABLE ACCURATE QUANTITATIVE MEASURE OF RESPIRATORY EFFORT
CAPNOGRAPHY
MEASURES CARBON DIOXIDE BY
1.) END-TIDAL= MEASURING FROM NOSE AND/OR MOUTH,TIGHT FITTING MASK TAKEN AT END OF EXPIRATION
NORMAL=35-45mmhg

2.) TRANSCUTANEOUS CO2 MEASUREMENT= PROBE HEATS SKIN AND HAS TO BE MOVED OFTEN
VARING WITH SKIN THICKNESS WITH ADULTS

SCORE HYPOVENTILATION DURING SLEEP IF >10mmhg
INCREASE PaCO2 DURING SLEEP IN CAMPARISON TO AWAKE SUPINE VALUE